Special Issue "3D Printing of Pharmaceuticals and Drug Delivery Devices"
A special issue of Pharmaceutics (ISSN 1999-4923).
Deadline for manuscript submissions: closed (31 December 2019).
A printed edition of this Special Issue is available here.
Interests: additive manufacturing (3D Printing & Bioprinting); drug delivery; electrospinning; microfluidics (micro/nano particle formulation & chip manufacturing); pharmaceutics
Special Issues and Collections in MDPI journals
Special Issue in Pharmaceutics: Nanotechnology Advances in Cancer Treatment
Special Issue in Materials: Polymeric Electrospun Nanofibers: Applications in Drug Delivery and Tissue Engineering
Special Issue in Polymers: Atomic Force Microscopy in Polymer Science
Special Issue in Pharmaceutics: Recent Development of Electrospinning for Drug Delivery
Special Issue in Pharmaceutics: Recent Development of Electrospinning for Drug Delivery Volume II
Special Issue in Pharmaceutics: Microfluidics as a Tool for Drug Delivery
Topical Collection in Pharmaceutics: 3D Printing and Bioprinting Applications in Pharmaceutics
Special Issue in Pharmaceutics: Novel Nanoparticles for Targeted Delivery of Therapeutic Nucleic Acids
Special Issue in Molecules: Novel Formulations and Pharmaceutical Materials to Improve Therapeutic Outcomes for Patients. A Themed Issue Dedicated to Professor Ryan F. Donnelly
Special Issue in Coatings: Antimicrobial Coatings for Touch Surfaces and Air-Filters in the Wake of COVID-19
The 3D printing (3DP) process was patented in 1986, however only in the last decade has it been used for medical applications, as well as being utilized in the fields of prosthetics, bio-fabrication, and pharmaceutical printing. 3DP or additive manufacturing (AM) is a family of technologies that implement layer-by-layer processes in order to fabricate physical models, based on a computer aided design (CAD) model. 3D printing permits the fabrication of high degrees of complexity with great reproducibility, in a fast and cost-effective fashion. 3DP technology offers a new paradigm for the direct manufacture of individual dosage forms, and has the potential to allow for variations in their size and geometry, varied to control the dose and release behavior. Furthermore, the low cost and ease of use of 3DP systems means that the possibility of manufacturing medicines and medical devices at the point of dispensing or at the point of use could become a reality. 3DP thus offers the perfect innovative manufacturing route to address this critical capability gap, hindering the widespread exploitation of personalized medicines and for molecules that are currently not easy to be deliver. This Special Issue will address new developments in the area of 3D printing and bioprinting for drug delivery applications, covering the recent advantages and future directions of additive manufacturing for pharmaceutical products. Original research papers and review articles are welcomed.
Dr. Dimitrios A. Lamprou
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- 3D Printing
- Additive Manufacturing
- Drug Delivery
- Computer-Aided Design (CAD)
- Finite Element Method (FEM)
- Fused Deposition Modelling (FDM)
- Inkjet Printing
- Personalized Medicine
- 3D Printing and Bioprinting Applications in Pharmaceutics in Pharmaceutics (28 articles)